XML 19 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Millions
Total
Abingworth
Common Stock
Common Stock
Abingworth
Additional Paid-in-Capital
Additional Paid-in-Capital
Abingworth
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Non- controlling Interests in Consolidated Entities
Beginning balance (in shares) at Dec. 31, 2021     355,400,000            
Beginning balance at Dec. 31, 2021 $ 5,706.2   $ 3.6   $ 2,717.6   $ 2,805.3 $ (247.5) $ 427.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares) (3,600,000)   (3,600,000)            
Shares repurchased $ (146.9)           (146.9)    
Equity-based compensation $ 147.0       147.0        
Shares issued for equity-based awards (in shares)     5,900,000            
Shares issued for performance allocations (in shares) 850,110   900,000            
Shares issued for performance allocations $ 38.9       38.9        
Shares issued related to the acquisition (in shares)     4,200,000 600,000          
Shares issued related to the acquisition 194.5 $ 25.0     194.5 $ 25.0      
Contributions 282.1               282.1
Dividends and distributions (498.9)           (325.4)   (173.5)
Net income 1,126.1           1,097.8   28.3
Non-controlling interests related to the acquisition of Abingworth 4.2               4.2
Currency translation adjustments (219.3)             (188.2) (31.1)
Defined benefit plans, net (4.0)             (4.0)  
Ending balance (in shares) at Sep. 30, 2022     363,400,000            
Ending balance at Sep. 30, 2022 6,654.9   $ 3.6   3,123.0   3,430.8 (439.7) 537.2
Beginning balance (in shares) at Jun. 30, 2022     361,200,000            
Beginning balance at Jun. 30, 2022 6,432.3   $ 3.6   3,033.6   3,309.9 (360.8) 446.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares)     (1,200,000)            
Shares repurchased (41.6)           (41.6)    
Equity-based compensation $ 62.0       62.0        
Shares issued for equity-based awards (in shares)     2,600,000            
Shares issued for performance allocations (in shares) 78,953   200,000            
Shares issued for performance allocations $ 2.4       2.4        
Shares issued related to the acquisition (in shares)       600,000          
Shares issued related to the acquisition   $ 25.0       $ 25.0      
Contributions 115.2               115.2
Dividends and distributions (135.2)           (118.3)   (16.9)
Net income 282.4           280.8   1.6
Non-controlling interests related to the acquisition of Abingworth 4.2               4.2
Currency translation adjustments (91.8)             (78.9) (12.9)
Ending balance (in shares) at Sep. 30, 2022     363,400,000            
Ending balance at Sep. 30, 2022 $ 6,654.9   $ 3.6   3,123.0   3,430.8 (439.7) 537.2
Beginning balance (in shares) at Dec. 31, 2022 362,298,650   362,300,000            
Beginning balance at Dec. 31, 2022 $ 6,821.3   $ 3.6   3,138.5   3,401.1 (322.2) 600.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares) (6,500,000)   (6,500,000)            
Shares repurchased $ (203.7)           (203.7)    
Equity-based compensation 192.3       192.3        
Shares issued for equity-based awards (in shares)     4,900,000            
Dividend-equivalent rights on certain equity-based awards 0.0       7.0   (7.0)    
Deconsolidation of a Consolidated Entity $ (110.4)               (110.4)
Shares issued for performance allocations (in shares) 0                
Contributions $ 99.0               99.0
Dividends and distributions (471.1)           (371.4)   (99.7)
Net income 173.6           83.6   90.0
Currency translation adjustments 4.9             (0.6) 5.5
Defined benefit plans, net $ (1.1)             (1.1)  
Ending balance (in shares) at Sep. 30, 2023 360,719,374   360,700,000            
Ending balance at Sep. 30, 2023 $ 6,504.8   $ 3.6   3,337.8   2,902.6 (323.9) 584.7
Beginning balance (in shares) at Jun. 30, 2023     360,000,000.0            
Beginning balance at Jun. 30, 2023 6,644.6   $ 3.6   3,266.5   2,992.9 (299.3) 680.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Shares repurchased (in shares)     (1,300,000)            
Shares repurchased (42.9)           (42.9)    
Equity-based compensation 68.9       68.9        
Shares issued for equity-based awards (in shares)     2,000,000.0            
Dividend-equivalent rights on certain equity-based awards 0.0       2.4   (2.4)    
Deconsolidation of a Consolidated Entity $ (103.3)               (103.3)
Shares issued for performance allocations (in shares) 0                
Contributions $ 43.5               43.5
Dividends and distributions (191.9)           (126.3)   (65.6)
Net income 111.0           81.3   29.7
Currency translation adjustments (24.1)             (23.6) (0.5)
Defined benefit plans, net $ (1.0)             (1.0)  
Ending balance (in shares) at Sep. 30, 2023 360,719,374   360,700,000            
Ending balance at Sep. 30, 2023 $ 6,504.8   $ 3.6   $ 3,337.8   $ 2,902.6 $ (323.9) $ 584.7